The effects of the novel dihydronaphthyridine Ca 2 + antagonist CI-951 on focal cerebral ischemia were assessed during MCA occlusion in 30 white New Zealand rabbits under 1.0% halothane anesthesia. In vivo brain pHj and focal CBF were measured with umbelliferone fluorescense. Baseline normocapnic brain pHj and CBF were 7.02 ± 0.02 and 48.4 ± 2.9 mUlOO g/min, respec tively. In the severe ischemic regions, 15 min postocclu sion brain pHj and CBF were 6.62 ± 0.04 and 14.4 ± 0.7 ml/lOO g/min in controls vs. 6.60 ± 0.02 and 12.9 ± 2.3 ml/lOO g/min, respectively, in animals destined to receive CI-951. Twenty minutes after MCA occlusion, CI-951 was administered at 0.5 fJ.. g/kg/min and brain pHj and CBF were determined in both regions of severe and moderate ischemia for 4 h postocclusion. Control severe ischemic
There are primarily two theoretical mechanisms by which calcium channel antagonists may attenu ate neuronal damage during focal cerebral ischemia: increasing blood flow and preventing calcium influx into ischemic neurons. First, improvement in CBF by calcium antagonists could be through reversal of ischemic vasoconstriction by preventing smooth muscle contraction in core regions of ischemia, by increasing pial collateral flow, or by retarding plate let aggregation (Aragno and Doni, 1976; Brandt et al. , 1983; Harris et al. , 1982; Meyer et al. , 1988) .
Second, calcium influx into ischemic neurons leads to activation of degradative metabolic cascades (Farber et al. , 1981; Siesj6, 1984) . Attenuation of neuronal calcium accumulation by Ca 2 + antago-sites demonstrated no significant improvement in brain pHj and only mild increases in CBF over the next 4 h. CI -951 caused significant improvement in both of these parameters. Postocclusion 4 h brain pHj and CBF mea sured 6.69 ± 0.04 and 18.5 ± 3.2 ml/IOO g/min in controls vs. 7.01 ± 0.04 and 41.7 ± 5.3 ml/l00 g/min, respectively, in CI-951 animals (p < 0.001). Similar improvements were observed in moderate ischemic sites. In animals that dem onstrated postocclusion EEG attenuation, 75% of CI-95 1 animals had EEG recovery as compared to 18% in con trols. CI-951 may be a useful therapeutic agent for focal cerebral ischemia if histological and outcome studies ver ify these data. Key Words: Focal cerebral ischemia Brain pH-CBF-Ca 2 + antagonists.
nists could conceivably retard ischemic neuronal in Jury.
Of the current classes of Ca H antagonists, the dihydropyridines have elicited considerable atten tion given their predilection for interacting with ce rebral vasculature and their ability to penetrate the blood-brain barrier (Kazda et aI., 1982; Godfraind et al. , 1986) . Within this group, the lipophillic dihy dropyridines, including nimodipine and PN200-110, appear to be most promising. Unfortunately, the effects of calcium channel antagonists including the dihydropyridines in focal cerebral ischemia remain equivocal (for example, Harper et al. , 1981; Smith et al. , 1983; Wiernsperger et aI., 1984; Mohammed et al. , 1985a Mohammed et al. , , 1985b Barnett et al. , 1986; Gotoh et al. , 1986; Hakim, 1986; Vorstrup et al. , 1986; Ger mano et al. , 1987) . The initial enthusiasm generated by improvements in cerebral blood flow in a variety of animal models has been tempered by the absence of consensus regarding beneficial effects on infarct size, metabolic parameters, or neurological out come. (Muster and Osswald, 1986; Osswald et al. , 1986; Dooley et al. , 1987) . It is highly lipophil lie, with a partition coefficient of 4. 67 and a molec ular weight of 420. Therefore, its penetration through the blood-brain barrier would at least be equivalent to nimodipine.
METHODS

Animal preparation
Thirty overnight fasted New Zealand white rabbits weighing between 3.0 and 3.5 kg were anesthetized with 4.0% inspired halothane, operated under 2.0% halothane, and studied under 1.0% halothane anesthesia. After tra cheostomy and placement of PE-50 catheters into the femoral artery and vein, pancuronium bromide 0.15 mg/ kg was administered to eliminate respiratory effort. The animals were maintained on a Harvard respirator and the mixture of inspired gases, respiratory rate, and tidal vol ume were adjusted to maintain a PaC0 2 of 40 torr.
A PE-IO catheter was placed into the ligated external carotid artery to facilitate injection of umbelliferone in a retrograde fashion into the internal carotid artery. The technique of catheter placement was such that flow through the internal carotid artery was maintained at all times. In the New Zealand white rabbit, the ventral ce rebral hemisphere is supplied solely by the ipsilateral in ternal carotid artery. The animal was then placed prone in a stereotactic headholder and a right craniotomy was per formed to expose both the middle cerebral artery (MCA) and hemisphere. The MCA was exposed through a retro orbital approach. The craniectomy was performed with a high-speed air drill under constant irrigation to prevent bone heating and with the aid of an Olympus operating microscope (8 x magnification). With this technique, no pressure was exerted against the underlying cortex, thereby preventing pressure contusions along the margins of the craniectomy. After bone waxing, the dura was removed and replaced with a thin sheet of plastic (Saran wrap). Total blood loss for the entire surgical preparation did not exceed 5 ml. The animals were maintained on a heating pad at a temperature of 37.0°C for the entire ex periment. Brain temperature was not measured.
Data recording
After surgical exposure, the animal was then trans ferred to an intravital microscope stage for fluorescence. Two measurements of focal cerebral blood flow and in tracellular brain pHj were then taken at two separate sites on the suprasylvian gyrus at a PaC0 2 of 40 torr. Only animals with normal preocclusion values were studied further.
The MCA was occluded with a microvascular clip dis tal to the origination of the lenticulostriates. Fifteen min utes afterwards, two sites of ischemia were identified for study: moderate and severe ischemic regions. Severe ischemic sites were defined as having a �80% reduction in CBF. These severe ischemic sites were topographically located in the direct distribution of the MCA and could be identified by cortical pallor prior to numerical confirma tion. Moderate ischemic sites were defined by a 50-60% reduction in CBF. These moderate ischemic sites were topographically located in distal border zones between the occluded MCA and collateral circulation (Meyer et aI., 1986) . Definition of these two levels of ischemia was based on prior experience with this model and is achiev able by the fact that the area of cortex assessed with umbelliferone fluorescence measures 80 f.Lm in diameter with a 500 f.Lm depth.
After identification of these two sites of ischemia, ei ther the drug or placebo was administered as a continuous intravenous infusion starting 20 min after MCA occlu sion. Therefore, identification of ischemic sites prior to drug infusion allowed the comparison of the effects of treatment in analogous sites of ischemia. Measurements of CBF and intracellular brain pH were measured hourly after MCA occlusion for a total of 4 h. During each hourly measurement, arterial blood gases, blood pressure, and hematocrit were measured.
Continuous electrocorticograms were recorded in all animals by stereotactic placement of gold-plated elec trodes through burr holes. Each cerebral hemisphere was monitored with two bipolar leads: frontal-temporal and frontal-parietal.
CBF and intracellular brain pH measurements
The instrumentation and techniques of in vivo fluo rescence of umbelliferone to determine brain pHj and CBF have been previously described (Sundt et aI., 1978; Sundt and Anderson, 1980) . Briefly, umbelliferone is a lipid soluble, pH-sensitive fluorescence indicator that is non toxic and isolated to intracellular compartments. Its ionic and molecular forms are fluorophors. The ratio of emis sion of the ionic and molecular forms when excited at 370 and 340 nm is pH sensitive. Emission is recorded at 450 nm. Prior to each experiment, a nomogram is constructed relating the ratio of 450 nm fluorescence of umbelliferone at 370 and 340 nm excitation with known pH buffers.
The microspectrofluorometer used measures a region of cortex 80 f.Lm in diameter. Since the blood-brain par tition coefficient is 1.0, umbelliferone clearance is a mea sure of perfusion through intracellular compartments. Therefore, in effect, it is focal CBF (Anderson et aI., 1987) . Focal CBF was determined by the washout curve of the molecular form of umbelliferone over a 60-s period commencing after the arterial spike using the I-min initial slope index. Changes in the pKa of the indicator related to binding to brain tissue have been published (Sundt and Anderson, 1980) . Briefly, there is no effect on the pKa of umbelliferone between a brain pH range of 6.2 to 7.6.
Drug preparations
The animals were randomly divided into two groups: 15 that received CI-95 1 at 0.5 fLg/kg/min and 15 that received the polyethylene glycol vehicle. CI-95 1 was mixed in the vehicle at a concentration of 1 mg/5 ml. This was further diluted in 0.9% NaCl to yield a final volume of 9 ml/h to be delivered intravenously after MCA occlusion. Prior to this experiment, preliminary nonischemic experiments were conducted in nine animals to determine the optimum dose of CI-95 1: three groups received either 0.25, 0.5, or 1.0 fLg/kg/min. The dose of CI-95 1 used in this experiment was the maximum dose permissible without causing sig nificant declines in mean arterial blood pressure. CI-95 1 was provided by Godecke Research Institute (Freiburg, F.R.G.).
Statistical analysis
The significance of each measurement of brain pHi and CBF in control and treated animals was calculated by either paired or unpaired t test at the specific time of measurement. The deviation from the mean is expressed as standard error of the mean.
RESULTS
Severe ischemia sites (Fig. 2) Pooling data from all 30 animals, at a PaC0 2 of 40 torr, baseline brain pHi was 7. 02 ± 0. 02 and focal CBF was 48. 4 ± 2.9 mlllOO g/min (Table 1) . Prior to middle cerebral artery occlusion, there were no sta tistical differences in either brain pHi of focal cere bral blood flow between controls and those animals destined to receive CI-951. Fifteen minute postoc clusion brain pHi and focal CBF were 6. 62 ± 0. 04 and 14. 4 ± 0. 7 ml/IOO g/min in controls vs. 6. 60 ± 0. 02 and 12. 9 ± 2. 3 mlllOO g/min, respectively, in animals destined to receive CI-195. There were no statistical differences between these two groups, in dicating that analogous sites of severity of ischemia were being compared prior to treatment. Adminis tration of CI-951 caused a significant improvement in both brain pHi and CBF. These improvements were observed 1 h postocclusion with brain pHi measuring 6. 86 ± 0. 07 in CI-951 animals vs. 6. 69 ± 0.03 in controls (p < 0. 005) while CBF was 32. 7 ± 6. 1 vs. 13. 8 ± 1. 3 mlllOO g/min, respectively (p < 0. 001). At 4 h postocclusion, brain pHi was normal at 7. 01 ± 0. 04 in CI-951 animals vs. 6.69 ± 0. 04 in controls (p < 0. 001) while focal CBF measured 41. 7 ± 5. 3 and 18.5 ± 3.2 mIll 00 g/min, respectively (p < 0. 001).
Moderate ischemia sites (Fig. 3) Fifteen minutes after MCA occlusion, brain pHi and CBF were 6. 67 ± 0. 04 and 23. 2 ± 1. 1 mlllOO g/min in controls vs. 6. 60 ± 0. 17 and 25. 0 ± 2. 0 mlllOO g/min, respectively, in animals scheduled to receive CI-951 (Table 2 ). There were no statistical differences between these two groups, indicating that analogous sites of moderate ischemia were be ing compared. Administration of CI-951 caused a rapid improvement in both brain pHi and CBF. For example, at 1 h postocclusion, brain pHi was 6. 94 ± 0. 07 in CI-951 animals vs. control values of 6. 72 ± 0. 03 (p < 0. 001) while CBF was 37. 7 ± 6. 3 and 23. 6 ± 2. 2 ml/lOO g/min, respectively (P < 0. 001). These significant improvements in both brain pHi and CBF were maintained for the duration of the exper iment. Four hours after MCA occlusion, brain pHi measured 7. 10 ± 0. 06 in CI-951 animals vs. 6.70 ± 0. 06 in controls while CBF was 45. 2 ± 6.9 and 24. 1 ± 3. 3 mlllOO g/min, respectively (p < 0.001). of the CI-951 animals demonstrated no EEG recov ery .
Systemic parameters
There were no significant differences in arterial blood gases, blood pressure, arterial pH, or hemat ocrit between the two groups. Of note was the he modilution that occurred. Pooling data from both groups, baseline hematocrit measured 45% and de clined to 36% at 4 h. Since there was not additional blood loss after the initial surgical preparation, this hemodilution was presumably a reflection of the volume of fluid administered for drug delivery and serial brain pHj and cerebral blood flow measure ments.
Death brain pHi
Immediately prior to killing, an umbelliferone bo lus was administered to allow death brain pHj mea surements. Twenty minutes after killing, in the pre viously severe ischemia sites, brain pHj measured 6. 42 ± 0. 04 in controls vs. 6. 40 ± 0. 03 in CI-951 animals.
DISCUSSION
These results demonstrate that CI-951 signifi cantly improved intracellular brain pH, focal cere bral blood flow, and EEG recovery in both regions of severe and moderate focal ischemia when admin istered 20 min after the onset of ischemia. There was a significant increase in CBF noted at the first hour followed by eventual normalization of blood flow in core regions of ischemia despite main trunk MCA occlusion. The fact that the death pH values both in controls and treated animals were not sta tistically different indicates that the reversal of ac idosis was not artifactual due to interference of CI-951 with the fluorescence methodology employed.
Since brain temperature was not measured, it is possible that mild cortical hypothermia developed since this was an open craniectomy model despite the use of a Saran wrap covering. Previous studies in a similar MCA occlusion model in the primate found that brain temperature was within OSC of body temperature and declined by 1.5-2.0°C during occlusion as measured by an infrared microscope (Anderson and Sundt, 1975) . However, in rabbits, where infarct size is not nearly as great, the ex pected temperature drop would be less. Since mild hypothermia may attenuate brain intracellular aci dosis, it is possible that the brain pHj measurements in both controls and CI-951 animals were amelio rated (Chopp et aI. , 1989) . However, since all ani mals were treated in an identical fashion, including maintenance of core body temperature, it is un- Occlusion 15 6.67 ± 0.04 6.60 ± 0.17 23.2 ± 1.1 25.0 ± 2.0 60
6.72 ± 0.03 6.94 ± 0.07** 23.6 ± 2.2 37.7 ± 6.3** 120
6.78 ± 0.04 7.05 ± 0.06** 27.2 ± 2.8 34.7 ± 4.1* 180
6.73 ± 0.05 7.04 ± 0.02** 22.7 ± 2.2 47.9 ± 6.5** 240
6.70 ± 0.06 7.10 ± 0.06** 24.1 ± 3.3 45.2 ± 6.9**
Values are mean ± SEM.
* p < 0.05 compared to control at the same time. ** p < 0.001 compared to control at the same time.
likely that potential brain hypothermia altered the significant differences in brain pHj between the two groups.
In this model, both regions of severe and moder ate ischemia were identified and studied. Prior his tological studies of this model have demonstrated that at 4 h after MCA occlusion, the severe isch emic sites are infarcted tissue. Alternatively, the moderate ischemic sites may be analogous to isch emic penumbras in that intermixed with normal ap pearing cells are dark pyknotic neurons indicative of ischemic injury (Meyer et aI. , 1986) . However, contrary to earlier work with this model, the control severe and moderate ischemic sites did not demon strate progressive declines in CBF and brain pHj.
One notable difference is that, in the current study, special attention was given to the effects of hydra tion. The decline in hematocrit in the control ani mals reflected hemodilution from continuous intra venous hydration with saline in addition to the intermittent umbelliferone boluses. Although pul monary wedge pressures were not measured, the significant decline in hematocrit with maintenance of arterial blood pressure indicates that euvolemic hemodilution was present. Potential improvements in rheological factors may explain why this control group did not deteriorate over the period of obser vation, as noted previously (Wood, 1982; Wood et al., 1982) . It is also possible that hemodilution en hanced the effects of CI-95 1.
The mechanism by which CI-951 improved both metabolic and electrical parameters of ischemic neurons was presumably due to primary increases in CBF. During ischemia, there are multiple path ways in which calcium may enter energy-depleted neurons, including the voltage-dependent and re ceptor-operated Ca 2+ channels and the Na + /Ca 2+ antiport (Godfraind et aI. , 1986; Miller, 1987 (Brandt et aI. , 1983; Meyer et aI. , 1988) . Main tenance of calcium gradients across the endoplas mic reticulum is energy dependent (Fitzpatrick et aI. , 1972) . During ischemia, there will be an influx of calcium into the smooth muscle cells causing cross-linking of myosin and actin filaments. The muscle will remain contracted until the level of free intracellular calcium drops to below 10-7 M. The attenuation of ischemic vasoconstriction and possi ble increases in pial collateral flow are the probable means by which certain dihydropyridines increase blood flow during focal ischemia. In addition, there is the possibility that dihydropyridines may retard platelet aggregation, thereby increasing microcircu latory flow (Aragno and Doni, 1976; 10uvin-Marche et aI. , 1983) .
Within the first 30 min of ischemia, there is a fourfold increase in lactic acid levels in MCA oc clusion in the squirrel monkey (Michenfelder and Sundt, 1971 ). The rapid decline in brain pHj as de tected by umbelliferone reflects this accumulation of lactate. This intracellular acidosis has several deleterious effects, including increasing glial edema that might reduce potential collateral flow, denatur ing of proteins with loss of enzymatic function, in terfering with NAD-NADH reduction, and increas ing free radical production (Rehncrona et aI. , 1980; Welsh et aI. , 1982; Plum, 1983; Siesjo et aI. , 1985) .
Therefore, the reversal of brain acidosis is primarily important, as opposed to simply being a reflection of the energy state of the tissue.
The improvement in CBF by CI-951 parallels prior findings in this laboratory in a similar model using nimodipine (Meyer et aI. , 1988) . In fact, the increases in CBF were more rapid than that previ ously observed with nimodipine. Clearly, it is not possible to compare experiments conducted several years apart. However, it is reasonable to conclude that the improvements in CBF, brain pHi' and EEG with CI-951 were minimally equal to that observed with nimodipine.
Despite the impressive improvements noted in this experimental paradigm, the potential clinical use of CI-951 awaits further histological and out come studies. A critical review of the reported use of various dihydropyridines like nimodipine, nicar dipine, and PN200-11O leaves only equivocal re sults. As indicated in the introduction, despite the relative agreement on documented increases in CBF in a variety of animal models, subsequent met abolic and pathological studies have been disap pointing. This disparity between laboratory results is partially reflected in recent clinical trials in which the beneficial effects of dihydropyridines during fo cal ischemia are marginal (Gelmers et aI. , 1988) .
